Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Ginseng, especially its component ginsenosides, can promote hair growth, reduce hair loss, and potentially treat conditions like alopecia by affecting cell pathways and cytokines.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

TLR2 is important for hair growth and can be targeted to treat hair loss.

VEGFR-2 activation is likely involved in hair follicle growth, survival, and development.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Finasteride may cause kidney damage.

Effective PCOS treatments require targeting specific signaling pathways.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

WWP2 is crucial for tooth development in mice.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Aging causes skin stem cells to work less effectively.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.